Status:
UNKNOWN
ELEVATE Acceptability Study
Lead Sponsor:
University Ghent
Collaborating Sponsors:
Horizon 2020 - European Commission
Universidade Nova de Lisboa
Conditions:
Cervical Cancer
HPV Infection
Eligibility:
FEMALE
25-65 years
Phase:
NA
Brief Summary
This study includes a community-based, two-arm prospective acceptability study, whereby arm 1 consists of an educational session on sexual health and cervical cancer (screening) and a follow-up assess...
Detailed Description
ELEVATE, a five-year project conducted by an international research alliance led by Ghent University, aims to develop a new test and approach for cervical cancer screening in hard-to-reach populations...
Eligibility Criteria
Inclusion
- are between the ages of 25 to 65 years of age, in line with the European Guidelines for initiating and stopping cervical cancer screening
- (ever been) sexually active;
- not diagnosed or in treatment for cervical cancer;
- not having had a hysterectomy
- not being pregnant
- Speaking the local language
Exclusion
- younger than 25 years old or older than 65 years old
- diagnosed or in treatment for cervical cancer
- having had a hysterectomy
- being pregnant
Key Trial Info
Start Date :
December 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
1048 Patients enrolled
Trial Details
Trial ID
NCT06136702
Start Date
December 7 2022
End Date
December 1 2024
Last Update
November 18 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
International centre for reproductive health
Ghent, East-Flanders, Belgium, 9000
2
Barretos Cancer Hospital - Fundação Pio XII
Barretos, Brazil
3
Universidad de Cuenca
Cuenca, Ecuador
4
Escola Nacional de Saúde Pública da Universidade NOVA de Lisboa
Lisbon, Portugal